Critical issues of HIV treatment in the era of highly active antiretroviral therapy

By Battegay M.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 2, 2001-02 ,pp. : 175-183

Informa Healthcare

Access to resources Recommend Favorite

Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients

By  

Current Pharmaceutical Design, Vol. 9, Iss. 18, 2003-07 ,pp. : 1475-1481

Bentham Science Publishers

Access to resources Recommend Favorite

Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management

By Calza L.   Manfredi R.   Chiodo F.  

International Journal of Antimicrobial Agents, Vol. 22, Iss. 2, 2003-08 ,pp. : 89-99

Elsevier

Access to resources Recommend Favorite

High Variability of Indinavir and Nelfinavir Pharmacokinetics in HIV-Infected Patients with a Sustained Virological Response on Highly Active Antiretroviral Therapy

By Goujard Cécile  

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1267-1278

Adis International

Access to resources Recommend Favorite

Therapeutic Drug Monitoring: A Tool to Individualize Highly Active Antiretroviral Therapy in HIV Infected Patients

By  

Current Pharmaceutical Analysis, Vol. 2, Iss. 3, 2006-08 ,pp. : 205-217

Bentham Science Publishers

Access to resources Recommend Favorite